Aurobindo Pharma Ltd. Financials

NSE BSE

15:59 Sep 12

Aurobindo Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1094.40

-14.80 (-1.33%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1094.40

-14.80 (-1.33%)
15:59 Sep 12

Quality

54/100
Medium Financial Strength

Valuation

46/100
Mid Valuation

Technical

41/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	23455.49	24855.38	29001.87	31723.73	32024.85
Operating Expenses +	19068.72	21136.74	23158.87	25140.94	25485.78
Raw Material	9323.6	11702.94	13549.07	13623.87	13820.16
Increase Decrease in Cost	816.68	-409.68	-946.17	-597.63	-627.38
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	3450.92	3522.25	3922.94	4475.62	4632.47
Miscellaneous Expenses	9381.06	10422.09	12178.89	13413.3	7660.53
Operating Profit	4386.77	3718.64	5843	6582.79	6539.07
Other Income	320.35	290.59	557.38	621.85	533.4
Depreciation	1126.52	1244.58	1521.66	1649.42	1650.94
Interest	48.64	140.48	289.71	457.24	443.95
Profit before tax and exceptio..	3531.96	2624.17	4589.01	5097.98	4977.58
Exceptional Items	-127.97	0	-191.86	0	0
PBT	3403.99	2624.17	4397.15	5097.98	4977.58
Provision for Taxation	725.63	684.85	1211.02	1582.72	1559.65
Net Profit	2678.36	1939.32	3186.13	3515.26	3417.93
NET Profit after MI	2648.15	1927.5	3172.97	3485.88	3391.41
EPS	45.19	32.9	54.16	59.81	58.32
Operating Profit Margin (%)	18.7	14.96	20.15	20.75	20.42
Net Profit Margin (%)	11.29	7.75	10.94	10.99	10.59

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	51.80	51.80	51.80	51.80	51.80
FII	14.40	15.30	16.30	16.60	16.70
MF	19.00	18.20	17.80	18.50	19.20
Others	7.90	8.10	7.40	6.60	5.60

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: